TRIATHLON SCREW-FIXATION TIBIAL BASEPLATE

K072575 · Stryker Orthopaedics · MBH · Jan 7, 2008 · Orthopedic

Device Facts

Record IDK072575
Device NameTRIATHLON SCREW-FIXATION TIBIAL BASEPLATE
ApplicantStryker Orthopaedics
Product CodeMBH · Orthopedic
Decision DateJan 7, 2008
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3565
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Triathlon® Screw-fixation tibial baseplates are intended for use in primary and revision total knee arthroplasty to alleviate pain and restore function. All total knee components presented in this submission are provided sterile for single-use.

Device Story

Triathlon® Screw-fixation Tibial Baseplate is a modification to the existing Triathlon® Total Knee System; provides screw-fixation option for cementless fixation in primary and revision total knee arthroplasty. Device consists of cast cobalt chrome baseplate with porous coating, optional peri-apatite (PA) coating, and compatible cobalt chrome bone screws (6.5mm diameter, 16-60mm lengths). Used by orthopedic surgeons in hospital operating rooms to replace diseased knee joints; restores function and alleviates pain. Baseplate integrates with existing Triathlon® CR, PS, and CS tibial inserts and patellae. Benefit to patient includes improved fixation stability in cementless TKR procedures.

Clinical Evidence

No clinical data provided. Substantial equivalence is based on design similarities and bench testing.

Technological Characteristics

Materials: Cast cobalt chrome, cobalt chrome porous coating, optional peri-apatite (PA) coating. Fixation: Cementless, screw-fixation. Dimensions: Sizes 1-8; screws 6.5mm diameter, 16-60mm lengths. Sterilization: Provided sterile. Connectivity: None. Software: None.

Indications for Use

Indicated for patients with painful, disabling knee joint disease (osteoarthritis, traumatic arthritis, avascular necrosis, rheumatoid arthritis, post-traumatic arthritis); post-traumatic loss of joint function; moderate varus, valgus, or flexion deformity; revision of unsuccessful knee replacement; or distal femur/proximal tibia fractures requiring stabilization. Posterior Stabilized (PS) components indicated for ligamentous instability or absent/non-functioning posterior cruciate ligament. Intended for cementless use only.

Regulatory Classification

Identification

A knee joint patellofemorotibial metal/polymer porous-coated uncemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device is designed to achieve biological fixation to bone without the use of bone cement. This identification includes fixed-bearing knee prostheses where the ultra high molecular weight polyethylene tibial bearing is rigidly secured to the metal tibial base plate.

Special Controls

*Classification.* Class II (special controls). The special control is FDA's guidance: “Class II Special Controls Guidance Document: Knee Joint Patellofemorotibial and Femorotibial Metal/Polymer Porous-Coated Uncemented Prostheses; Guidance for Industry and FDA.” See § 888.1 for the availability of this guidance.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K072575 #1/2 # 510(k) Summary of Safety and Effectiveness for the Triathlon® Screw-Fixation Tibial Baseplate | Proprietary Name: | Triathlon® Screw-fixation Tibial Baseplate JAN - 7 2008 | |-----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Common Name: | Total Knee Joint Replacement Prosthesis | | Classification Name and Reference | Knee joint patellofemorotibial metal/polymer<br>porous-coated uncemented prosthesis.<br>21 CFR §888.3565 | | Regulatory Class: | Class II | | Device Product Code: | 87 MBH - prosthesis, knee, patello/femorotibial,<br>semi-constrained, uncemented, porous, coated,<br>polymer/metal/polymer, | | For Information contact: | Francisco Haro<br>Regulatory Affairs Specialist<br>Stryker Orthopaedics<br>325 Corporate Drive<br>Mahwah, New Jersey 07432<br>Phone: (201) 831-5493<br>Fax: (201) 831-6038<br>E-Mail: Frank.Haro@stryker.com | | Date Summary Prepared: | December 6, 2007 | #### Device Description The tibial baseplates of the Triathlon® Total Knee System has been modified to include a screwfixation option for use with existing Triathlon® Total Knee components. The subject tibial baseplate is porous coated and will be available with and without Howmedica Osteonics' Periapatite (PA) coating. The Triathlon® fixed bearing cementless tibial baseplates are compatible with Triathlon® CR, PS, and CS tibial inserts and patellae. The Triathlon® components proposed in this submission are manufactured from cast cobalt chrome and have a cobalt chrome porous coating, available with and without a peri-apatitie coating. The Triathlon® tibial component is fixed bearing and will be provided in sizes 1 through 8. Compatible cobalt chrome bone screws are also included in this submission in 6.5mm diameter with lengths of 16mm, and 20mm to 60mm in 5mm increments. {1}------------------------------------------------ K072575 # 2/8 ## Intended Use: The Triathlon® Screw-fixation tibial baseplates are intended for use in primary and revision total knee arthroplasty to alleviate pain and restore function. All total knee components presented in this submission are provided sterile for single-use. #### Indications General Total Knee Arthroplasty (TKR) Indications: - Painful, disabling joint disease of the knee resulting from: noninflammatory degenerative . joint disease (including osteoarthritis, traumatic arthritis, or avascular necrosis), rheumatoid arthritis or post-traumatic arthritis. - Post-traumatic loss of knee joint configuration and function. . - . Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability. - . Revision of previous unsuccessful knee replacement or other procedure. - . Fracture of the distal femur and/or proximal tibia that cannot be stabilized by standard fracture management techniques. Additional Indications for Posterior Stabilized (PS) Components: - . Ligamentous instability requiring implant bearing surface geometries with increased constraint. - . Absent or non-functioning posterior cruciate ligament. The Triathlon® Screw-fixation Tibial Baseplates are intended for cementless use only. #### Substantial Equivalence: The determination of the substantial equivalence of the Triathlon® Screw-fixation tibial baseplate is based on its similarities in intended use, design and sterilization to Howmedica Osteonics' Triathlon® Total Knee System (K051380, cleared 30 August 2005) and Duracon® Total Knee System (K032418 cleared, 11 September 2003). {2}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service JAN - 7 2008 ood and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Stryker Orthopaedics % Mr. Francisco Haro Regulatory Affairs Specialist 325 Corporate Drive Mahwah, NJ 07430 > K072575 Trade/Device Name: Triathlon Screw-Fixation Tibial Baseplate Regulation Number: 21 CFR 888.3565 Regulation Name: Knee joint patellofemorotibial metal/polymer porous-coated uncemented prosthesis Regulatory Class: Class II Product Code: MBH Dated: December 6, 2007 Received: December 7, 2007 Dear Mr. Haro: Re: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ Page 2 - Mr. Francisco Haro This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely vours, Mark M. Wilkerson Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # 510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________ Device Name: ## Indications General Total Knee Arthroplasty (TKR) Indications: - Painful, disabling joint disease of the knee resulting from: noninflammatory degenerative . joint disease (including osteoarthritis, traumatic arthritis, or avascular necrosis), rheumatoid arthritis or post-traumatic arthritis. - Post-traumatic loss of knee joint configuration and function. . - Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be . returned to adequate function and stability. - Revision of previous unsuccessful knee replacement or other procedure. � - Fracture of the distal femur and/or proximal tibia that cannot be stabilized by standard . fracture management techniques. Additional Indications for Posterior Stabilized (PS) Components: - Ligamentous instability requiring implant bearing surface geometries with increased . constraint. - Absent or non-functioning posterior cruciate ligament. . The Triathlon® Screw-fixation Tibial Baseplates are intended for cementless use only. Prescription Use OR (Per 21 CFR 801.109) Over-the-Counter Use (PLEASE DO NOT WRITE BELOW THIS LINE --- CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Samuel B. Payne (Division Sign-Off) Division of General. Restorative. and Neurological Devices **510(k) Number** K072575
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...